BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28593503)

  • 1. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
    Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
    Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma.
    Zhu C; Utsunomiya T; Ikemoto T; Yamada S; Morine Y; Imura S; Arakawa Y; Takasu C; Ishikawa D; Imoto I; Shimada M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S729-35. PubMed ID: 24992910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
    Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
    Ramzy II; Omran DA; Hamad O; Shaker O; Abboud A
    Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.
    Gao XD; Qu JH; Chang XJ; Lu YY; Bai WL; Wang H; Xu ZX; An LJ; Wang CP; Zeng Z; Yang YP
    Liver Int; 2014 Jan; 34(1):136-46. PubMed ID: 23875825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ; Huang Y; Wei L; He JY; Liu QY; Yu XQ; Li ZL; Zhang J; Li B; Sun CJ; Liang WB; Sun AM; Qin Y
    Neoplasma; 2017; 64(5):795-802. PubMed ID: 28592132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
    Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P; Hourpai N; Rattanatanyong P; Wisedopas N; Mahachai V; Mutirangura A
    Clin Chim Acta; 2007 Apr; 379(1-2):127-33. PubMed ID: 17303099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
    Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
    Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
    Anwar SL; Hasemeier B; Schipper E; Vogel A; Kreipe H; Lehmann U
    PLoS One; 2019; 14(5):e0216374. PubMed ID: 31059558
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
    Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
    Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.
    Lee YR; Kim G; Lee HW; Tak WY; Park SY; Jang SY; Kweon YO; Park JG; Han YS; Chun JM; Han JR; Hur K
    Medicine (Baltimore); 2021 Apr; 100(16):e25552. PubMed ID: 33879706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.
    Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L
    Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
    Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
    Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma.
    Cui LH; Quan ZY; Piao JM; Zhang TT; Jiang MH; Shin MH; Choi JS
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.